Skip to content

Clinical trials

Phase 1/2 Diabetic Nephropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 1/2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20133
20141
20161
20171
20182
20191
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation2
University of Colorado, Denver2
Eli Lilly and Company1
Glycadia1
Mario Negri Institute for Pharmacological Research1
Mesoblast, Ltd.1
National Center for Complementary and Integrative Health (NCCIH)1
PT. JES Kasih Nusantara Sejahterah1
PT. Prodia Stem Cell Indonesia1
Sharma, Kumar, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies15
Kidney Diseases6
Diabetes Mellitus4
Diabetes Complications2
Diabetes Mellitus, Type 12
Diabetes Mellitus, Type 22
Renal Insufficiency, Chronic2
Disease Progression1
Metabolic Diseases1
Obesity1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.